tiprankstipranks
Trending News
More News >
Relmada Therapeutics (RLMD)
NASDAQ:RLMD
US Market

Relmada Therapeutics (RLMD) Technical Analysis

Compare
337 Followers

Technical Sentiment

Overall Consensus
Buy
12Bullish
2Neutral
8Bearish
Technical Analysis Consensus
Sell
3Bullish
2Neutral
5Bearish
Moving Average Consensus
Buy
9Bullish
0Neutral
3Bearish
Relmada Therapeutics’s (RLMD) Moving Averages Convergence Divergence (MACD) indicator is 0.08, suggesting Relmada Therapeutics is a Sell.
Relmada Therapeutics’s (RLMD) 20-Day exponential moving average is 0.40, while Relmada Therapeutics’s (RLMD) share price is $0.64, making it a Buy.
Relmada Therapeutics’s (RLMD) 50-Day exponential moving average is 0.41, while Relmada Therapeutics’s (RLMD) share price is $0.64, making it a Buy.

Relmada Therapeutics (RLMD) Pivot Points

Apr 27, 2025, 05:39 PM
Name
S3
S2
S1
Pivot Points
R1
R2
R3
Classic
0.39
0.46
0.60
0.68
0.82
0.89
1.03
Fibonacci
0.46
0.55
0.60
0.68
0.76
0.81
0.89
Pivot points are a technical analysis tool used by traders to identify potential support and resistance levels in financial markets. Pivot points are calculated based on the previous day's high, low, and close prices, and are used to help traders identify levels at which the price may reverse or continue to trend.

Relmada Therapeutics (RLMD) Moving Averages

Apr 27, 2025, 05:39 PM
Period
Simple
Exponential
MA5
0.55Buy
0.58Buy
MA10
0.43Buy
0.48Buy
MA20
0.35Buy
0.40Buy
MA50
0.31Buy
0.41Buy
MA100
0.43Buy
0.76Sell
MA200
1.85Sell
1.70Sell
Relmada Therapeutics’s (RLMD) 10-Day exponential moving average is 0.48, while Relmada Therapeutics’s (RLMD) share price is $0.64, making it a Buy.
Relmada Therapeutics’s (RLMD) 100-Day exponential moving average is 0.76, while Relmada Therapeutics’s (RLMD) share price is $0.64, making it a Sell.
Relmada Therapeutics’s (RLMD) stock price is $0.64 and Relmada Therapeutics’s (RLMD) 50-day simple moving average is 0.31, creating a Buy signal.
Relmada Therapeutics’s (RLMD) stock price is $0.64 and Relmada Therapeutics’s (RLMD) 100-day simple moving average is 0.43, creating a Buy signal.
Relmada Therapeutics’s (RLMD) stock price is $0.64 and Relmada Therapeutics’s (RLMD) 200-day simple moving average is 1.85, creating a Sell signal.

Relmada Therapeutics (RLMD) Technical Indicators

Apr 27, 2025, 05:39 PM
Name
Value
Implied Action
RSI (14)
73.84
Sell
STOCH (9,6)
90.43
Sell
STOCHRSI (14)
90.92
Sell
MACD (12,26)
0.08
Sell
ADX (14)
28.51
Neutral
Williams %R
-22.31
Buy
CCI (14)
215.22
Sell
ATR (14)
0.08
-
Ultimate Oscillator
69.84
Neutral
ROC
137.04
Buy
Relmada Therapeutics’s (RLMD) Relative Strength Index (RSI) is 73.84, creating a Sell signal.
Relmada Therapeutics’s (RLMD) Trend Strength Indicator (ADX) is 28.51, creating a Neutral signal.
Relmada Therapeutics’s (RLMD) Commodity Channel Index (CCI) is 215.22, creating a Sell signal.
Relmada Therapeutics’s (RLMD) Price Rate of Change (ROC) is 137.04, creating a Buy signal.

FAQ

Is RLMD a Buy, Hold, or Sell?
Based on RLMD’s technical indicators, RLMD is a Buy.
    What is RLMD’s RSI (14)?
    RLMD’s RSI (14) is 73.84, which suggests RLMD is a Sell.
      What is RLMD’s MACD?
      RLMD’s MACD is 0.08, which suggests RLMD is a Sell.
        What is RLMD’s 5-day moving average?
        RLMD’s 5-day moving average is 0.55, which suggests RLMD is a Buy.
          What is RLMD’s 20-day moving average?
          RLMD 20-day moving average is 0.35, which suggests RLMD is a Buy.
            What is RLMD’s 50-day moving average?
            RLMD’s 50-day moving average is 0.31, which suggests RLMD is a Buy.
              What is RLMD’s 200-day moving average?
              RLMD’s 200-day moving average is 1.85, which suggests RLMD is a Sell.
                What is RLMD’s Williams % R (14)?
                RLMD’s Williams % R (14) is -22.31, which suggests RLMD is a Buy.
                  What is RLMD’s CCI (14)?
                  RLMD’s CCI (14) is 215.22, which suggests RLMD is a Sell.
                    What am I Missing?
                    Make informed decisions based on Top Analysts' activity
                    Know what industry insiders are buying
                    Get actionable alerts from top Wall Street Analysts
                    Find out before anyone else which stock is going to shoot up
                    Get powerful stock screeners & detailed portfolio analysis